EPO and neoplasm: Our results indicate that, at least in our cases, pituitary adenomas are EPOR-negative tumors and rhEPO administration accelerates the growth of pituitary adenomas by promoting tumor angiogenesis via the EPO-JAK2-STAT3-VEGF signaling pathway.